Management of Urgent Bleeding in Patients with Hemophilia A: Focus on the Use of Emicizumab

Abstract

Management of patients with hemophilia A (HA) requires the knowledge and experience of specialized health care professionals. However, these patients may need to be attended in emergencies, outside the referral hospital, where health care professionals do not know about hemophilia and/or new innovative treatments.

Keywords

• hemophilia
• emicizumab
• emergency
• bleeding
• inhibitors